Dear readers! We present to your attention the third issue of the LOGISTICS journal for 2025. Our editorial staff, like all our colleagues, is preparing for the TransRussia 2025 exhibition, the largest event in the industry. In this issue, we have prepared an interview with Natalia Lomunova, Director of TransRussia, with whom we are talking about a flexible approach, new participants and digital services. We continue the series of articles from P.V.
Dear readers! We present to your attention the first issue of the LOGISTICS journal in 2025. First of all, we would like to draw readers' attention to our new partner R1 Development, a development company that creates a new generation environment and specializes in the construction of industrial, logistics, commercial and residential real estate. One of the projects of R1 Development is the Druzhba industrial park network.
Dear readers! We present to your attention the final issue of the LOGISTICS journal in 2024. We have tried to make it rich and interesting. Today, many Russian companies operate under strict sanctions restrictions, which force them to reorient logistics flows. One of the possible solutions to this problem may be the Russia – Mongolia – China economic corridor. Details can be found in the article by Alexandra Kazunina.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Bonn/Germany, September 16, 2021: COVID-19 has become the largest global health crisis in a century. Governments, NGOs, and public authorities have focused on containing the virus, accelerating vaccination programs to keep populations safe, and ensuring that economies recover quickly. Since the global vaccine campaign began in December 2020, DHL has safely delivered more than 1 billion COVID-19 vaccine doses to more than 160 countries, playing a key role in the global vaccination roll-out.
“Looking back at the state of emergency these past nine months, we are honored to be playing our part, seamlessly managing and executing multiple supply chain set-ups without cold chain interruptions or security incidents. We are working across multiple supply chain set-ups and managing direct distributions in certain countries. We implemented new, dedicated, and reliable services at an accelerated speed to ship the highly temperature-sensitive vaccines, as well as ancillary supplies and test kits. In line with our purpose of ‘Connecting people, Improving Lives’, we will continue tapping into our cold chain infrastructure, resilient global network, and deep pharmaceutical logistics knowledge and experience of our people”, says Katja Busch, Chief Commercial Officer DHL.
The global vaccination campaign represents a crucial instrument in the fight against the virus, and it is essential for containing further virus variants. To reach high immunization levels, around 10 billion vaccine doses will be required worldwide by the end of 2021. The global distribution of these doses is necessary to ensure that as many people as possible have access to vaccines. Besides managing various and complex supply chain set-ups, the sensitive temperature requirements have been a major challenge for logistics experts.
“Our advantage is that we already had a sophisticated network in place with the necessary healthcare expertise. This allowed us to react swiftly”, explains Claudia Roa, President of Life Sciences & Healthcare at DHL Customer Solutions & Innovation. “We ship the vaccines in special active thermal containers equipped with state-of-the-art GPS temperature trackers to ensure consistent temperatures and provide full transparency throughout the entire journey.”
DHL Global Forwarding and DHL Express have been tasked with transporting COVID-19 vaccines on multiple routes from Europe and other origins to countries across Asia Pacific, South America, and Europe. DHL Supply Chain is responsible for the proper storage and local distribution of the vaccines in several German states.
“Making a meaningful difference is what drives us, and we are proud of our contribution to the enormous task of delivering COVID-19 vaccines and related critical medical supplies to the right place at the right time, worldwide”, says Thomas Ellmann, Vice President of Life Sciences & Healthcare, DHL Customer Solutions & Innovation. “The current COVID-19 situation clearly demonstrates how collaboration across governments and NGOs, pharmaceutical companies, medical equipment manufacturers, and logistics companies is the only way to beat pandemics, both now and in the future.”
 |
 |
